CTY
City Therapeutics Inc.
NASDAQ · Healthcare · Biotechnology · US
$21.46
−4.20%Leverage
- Debt / equity
- 0.46x
- Net debt / equity
- 0.46x
- Debt / assets
- 0.24x
- Debt / EBITDA
- 1.30x
- Net debt / EBITDA
- 1.30x
Liquidity & coverage
- Current ratio
- 0.44x
- Quick ratio
- 0.44x
- Cash ratio
- 0.00x
- Interest coverage
- 14.83x
- EBITDA / interest
- 18.76x
- Working capital
- -$1.4B
Cash & dividend
- FCF / debt
- 0.47x
- Cash flow / debt
- 0.71x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2020